There is hope. Researchers and biotech firms are moving at an unprecedented pace to develop vaccines against the coronavirus, using the virus' genetic code to try to stimulate an immune response in uninfected patients. Other researchers are analyzing the blood of patients who've recovered from COVID-19, in the hope that their immunity can be transferred to other people.